Cheryl Bandoski Gralinski
About Cheryl Bandoski Gralinski
Cheryl Bandoski Gralinski is a Senior Research Associate in Therapeutic Discovery at StrideBio, Inc., with a strong academic background in Cellular and Molecular Biology. She has held various research and scientific roles at several institutions, including Bristol-Myers Squibb and the University of New Haven.
Current Role at StrideBio
Cheryl Bandoski Gralinski serves as a Senior Research Associate in Therapeutic Discovery at StrideBio, Inc. She has held this position since 2021. In her role, she contributes to the development of innovative therapeutic solutions, leveraging her extensive background in cellular and molecular biology.
Previous Experience in Research and Development
Prior to her current position, Gralinski worked in various research and development roles. She was an Associate Scientist at Bristol-Myers Squibb from 2017 to 2020, focusing on Selection Technologies and Protein Engineering. She also served as a Research Associate II at T2 Biosystems from 2015 to 2016, where she specialized in Molecular Diagnostic Assay Development. Her experience includes a role as an Associate Scientist at MedPharm Ltd from 2020 to 2021.
Academic Background in Cellular and Molecular Biology
Gralinski earned her Master of Science in Cellular and Molecular Biology from the University of New Haven, completing her studies from 2012 to 2014. She also pursued graduate courses in the same field at Harvard University Extension School from 2009 to 2012. Her foundational education includes a Bachelor of Science in Biology from the University of Massachusetts Dartmouth, which she completed from 2005 to 2009.
Research Experience at University of New Haven
During her time at the University of New Haven, Gralinski worked as a Thesis Research Fellow and Research Assistant in Dr. Eva Sapi's lab from 2013 to 2014. This role provided her with hands-on experience in research methodologies and contributed to her expertise in cellular and molecular biology.
Early Career in Biotechnology
Gralinski began her career in biotechnology as a Production Associate I at Organogenesis Inc. from 2009 to 2011. This role laid the groundwork for her subsequent positions in research and development within the life sciences sector.